CAR NKT cells offer a promising novel immunotherapy for solid tumors

OPACC
Oct 14, 2020
1 min read

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with cancer.

Comments

Pediatric Patients and Parents Say They Want Straight Talk from Oncologists Even When the Prognosis Is Poor

Yale study links childhood thyroid cancer risk to air and light pollution

Forecasting the future for childhood cancer survivors

Nemours study points to need for more psychosocial support for childhood cancer treatment

AHA Scientific Statement on CV Toxicity in Patients Treated for Childhood Cancer

Female AYA Cancer Survivors May Benefit From Increased Physical Activity

Nutrition is a key ingredient for defense against infectious diseases in kids with cancer

Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors

Cardiometabolic Considerations for Childhood Cancer Survivors Explained

Sex and Age May Influence Comorbidities in Pediatric ALL

Recent Posts